Nephrogenic Systemic Fibrosis in Patients with Advanced Renal Dysfunction Following Gadolinium-based Contrast Agents
Adarsh Mallepally, Jason M. Kidd, John D. Grizzard, Huzaefah Syed, Nitin Chetla, Laura R. Carucci, Shawn E. Cowper, Cory R. Trankle
原始摘要（英文原文）· Original abstract
In patients with stage 4 or 5 chronic kidney disease or end-stage renal disease who received gadolinium-based contrast agents since 2010, diagnostic codes for potential nephrogenic systemic fibrosis or mimics were exceedingly rare.